QULEAP

Welcome to the Brand page for “QULEAP”, which is offered here for Downloadable computer software for drug discovery; downloadable computer software for the purpose of enabling automated molecular design; downloadable computer software for automated molecular design; downloadable computer software for design of molecules and synthetic chemicals using a biomolecular algorithm; downloadable computer software for biomolecule simulation in connection with drug and chemical design; downloadable computer software utilizing artificial intelligence and machine learning for biomolecule simulation and synthetic chemistry; downloadable computer software for validating novel disease-related targets; downloadable computer software incorporating artificial intelligence and quantum computing functions to automate drug and chemical discovery and development; downloadable computer software incorporating artificial intelligence and quantum computing functions to automate synthetic chemical discovery and development; downloadable computer software for computational automation of synthetic chemicals; downloadable computer software incorporating machine learning algorithms, models, and solutions for applications in pharmacology, biopharmaceuticals, energy, and optoelectronics; downloadable computer software for manipulating molecules; downloadable computer software for use in connection with pharmaceutical research and development in the fields of oncology, immunology, cardiology, pulmonology, cns, psychiatry, dermatology, and endocrinology; downloadable computer software for pharmaceutical research and development in connection with infectious diseases, diabetes, metabolic diseases, internal diseases, and respiratory diseases;providing temporary use of non-downloadable cloud-based computer software for drug discovery; providing temporary use of non-downloadable cloud-based computer software for the purpose of enabling automated molecular design; providing temporary use of non-downloadable cloud-based computer software for automated molecular design; providing an online, non-downloadable computer software platform for design of molecules and synthetic chemicals using a biomolecular algorithm; providing an online, non-downloadable computer software platform for biomolecule simulation in connection with drug and chemical design; providing an online, non-downloadable computer software platform utilizing artificial intelligence and machine learning for biomolecule simulation and synthetic chemistry; providing an online, non-downloadable computer software platform for validating novel disease-related targets; providing temporary use of non-downloadable cloud-based computer software incorporating artificial intelligence and quantum computing functions to automate drug and chemical discovery and development; providing temporary use of non-downloadable cloud-based computer software incorporating artificial intelligence and quantum computing functions to automate synthetic chemical discovery and development; providing temporary use of non-downloadable cloud-based computer software for computational automation of synthetic chemicals; providing temporary use of non-downloadable cloud-based computer software incorporating machine learning algorithms, models, and solutions for applications in pharmacology, biopharmaceuticals, energy, and optoelectronics; providing temporary use of non-downloadable cloud-based computer software for manipulating molecules; providing temporary use of non-downloadable cloud-based computer software for use in connection with pharmaceutical research and development in the fields of oncology, immunology, cardiology, pulmonology, cns, psychiatry, dermatology, and endocrinology; providing temporary use of non-downloadable cloud-based computer software for pharmaceutical research and development in connection with infectious diseases, diabetes, metabolic diseases, internal diseases, and respiratory diseases;.

Its status is currently believed to be active. Its class is unavailable. “QULEAP” is believed to be currently owned by “Qulab Inc.”